TrademarkDir
SIMLANDI (ADALIMUMAB-RYVK) INJECTION 40MG/0.4ML
DEAD

Serial Number

98851706

Owner

Teva Pharmaceuticals USA, Inc.

Attorney

Laurence Rickles

First Use Date

Mar 1, 2024

Filing Date

Nov 13, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

SIMLANDI (ADALIMUMAB-RYVK) INJECTION 40MG/0.4ML Trademark

Serial Number: 98851706

SIMLANDI (ADALIMUMAB-RYVK) INJECTION 40MG/0.4ML is a trademark filed by Teva Pharmaceuticals USA, Inc. on November 13, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Teva Pharmaceuticals USA, Inc. (589 trademarks)

650 Cathill Road
Sellersville, PA 18960

Entity Type: 03

Trademark Details

Filing Date

November 13, 2024

Registration Date

Not Registered

First Use Anywhere

March 1, 2024

First Use in Commerce

March 1, 2024

Goods & Services

Injectors for medical purposes, namely, medical fluid injectors

Pharmaceutical preparations for the treatment of autoimmune diseases

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 26, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 26, 2025 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 14, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 14, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 14, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 14, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 14, 2025 CNRT
ASSIGNED TO EXAMINER
May 8, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 7, 2025 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 7, 2025 NWOS
NEW APPLICATION ENTERED
Nov 13, 2024 NWAP

Related Trademarks

More from this Owner

GOMOSDI

GOMOSDI

DEJEVMA

DEJEVMA

WILPAXA

WILPAXA

OLZENDY

OLZENDY

WELTRUZA

WELTRUZA

WELTRUZA

WELTRUZA